Home › Mielofibrosi › Florida › Miami
Studi clinici su Mielofibrosi a Miami, FL
10 studi su Mielofibrosi cercano partecipanti presso sedi a Miami e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
In reclutamentoFase 1/2
- University of Miami, Miami
- Baptist Health - Miami Cancer Institute, Miami
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
In reclutamentoFase 3
- Miami NS Ins Baptist Health S FL, Miami
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
In reclutamentoFase 3
- Bioresearch Partners, Miami
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
In reclutamentoFase 2
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
In reclutamentoFase 1/2
- Sylvester Cancer Center - U Miami, Miami
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
In reclutamentoFase 1
- University of Miami, Miami
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
In reclutamentoFase 1
- University of Miami Health System, Miami
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
In reclutamentoFase 2
- University of Miami, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Miami
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
In reclutamentoFase 3
- University of Miami, Miami
Studi su Mielofibrosi in altre città
- Houston, TX19 studi
- New York City, NY18 studi
- Boston, MA12 studi
- Durham, NC12 studi
- Columbus, OH11 studi
- Seattle, WA11 studi
- Salt Lake City, UT10 studi
- Nashville, TN9 studi
- Cleveland, OH9 studi
- Tampa, FL9 studi
- Atlanta, GA9 studi
- Baldwin Park, CA9 studi
Altri studi a Miami
- Cancro al seno42 studi
- Cancro (tutti i tipi)36 studi
- Cancro del polmone non a piccole cellule31 studi
- Cancro alla prostata27 studi
- Obesità27 studi
- Leucemia mieloide acuta24 studi
- Cancro metastatico24 studi
- Cancro ovarico23 studi
- Sovrappeso23 studi
- Mieloma multiplo21 studi
- Colite ulcerosa21 studi
- Morbo di Alzheimer20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.